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ABSTRACT 
The enhancement in solubility and dissolution rate of BCS class-II drug Nifedipine was achieved by simple physical mixture with 
sepitrap 80 & sepitrap 4000 in 1:1 & 1:2 proportion. The saturation solubility studies shows 263 % & 368 % increase in the 
solubility in physical mixture of Nifedipine with sepitrap 80 & sepitrap 4000 respectively. The physicochemical properties of pure 
Nifedipine compared to their physical mixtures with sepitrap 80 & sepitrap 4000 were determined using FTIR, DSC & PXRD. The 
FTIR and DSC studies shows no any interaction in Nifedipine and sepitrap, the marked broadening and distinct reduction in intensity 
with shifting of drug endotherm was displayed physical mixture with sepitrap demonstrate positive effect. The PXRD diffractograms 
shows distinctive peaks but reduction in peak intensity in terms of counts indicating conversion of drug in amorphous forms. The 
surface morphology of the prepared physical mixture was examined by SEM which indicating no significant change in its surface 
morphology due to no use any solvent during the preparation of physical mixture . Photostability studies shows that rate of photo 
degradation is very slow in Physical mixture with sepitrap as compared to pure Nifedipine. Dissolution studies in SGF & SIF shows 
that significant enhancement by use of novel solubilizer sepitrap 80 as well as sepitrap 4000 in 1:2 proportions. The physical mixture 
containing sepitrap 4000 was found stable as there was no any significant change in appearance and drug dissolution after three 
month stability studies. 
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1. INTRODUCTION 
Nifedipine is an oral calcium-channel blocking agent, 
widely used in the treatment of angina pectoris and 
hypertension. Nifedipine is a poorly water-soluble drug 
and its oral bioavailability is very low. Diseases like 
angina, asthma, epilepsy etc. require immediate drug re-
sponse to manage the disease condition. Improvement of 
the aqueous solubility of poorly water-soluble drugs is 
one of the important factors for the enhancement of 
absorption and obtaining adequate oral bioavailability 
1
. 
The various methods reported till the date for dissolution 
rate enhancement of Nifedipine (model drug) include 
compaction with hydroxypropylmethylcellulose 
2
, co-
grinding with HPMC 
3
 or bile salts 
4
, formation of solid 
dispersions as co-precipitates or co-evaporates with 
mannitol
5
, phosphatidylcholine esters 
6
, HPMC 
7
, 
Chitosan derivatives 
8
, polyethylene glycols 
9
 and 
polyoxyethylene–polyoxypropylene copolymers 10, and 
inclusion complexes with beta-cyclodextrin 
11
. 
Jagtap et al                                                                                                     Journal of Drug Delivery & Therapeutics. 2018; 8(5-s):293-300           
ISSN: 2250-1177                                                                             [294]                                                                             CODEN (USA): JDDTAO 
In addition to the common solubility enhancement 
techniques which was reported by various researchers 
the use of novel solubilizer is one of the challenging 
approach for enhancement of solubility of poorly soluble 
drug  like Nifedipine. The use of novel solubilizer like 
SEPITRAP 80 & SEPITRAP 4000 got an attention 
because simplicity of process that is no need to go for 
any complex procedure which may need to perform in 
above mentions methods. Only simple physical mixture 
of API with SEPITRAP 80 & SEPITRAP 4000 in 
various proportions is most prominent for enhancement 
of solubility and dissolution rate of poorly soluble drug 
like Nifedipine from solid oral formulations 
12
. The 
exposure of some drugs to light leads to 
photodecomposition. These drugs undergo important 
chemical changes, accompanied by alternation in their 
activities and in some cases total loss of their therapeutic 
activity 
13
. Nifedipine is very highly sensitive to photo 
oxidation & photodegradated products have no 
pharmacological activity 
14,15 
hence there is necessary to 
protect during formulation and need to evaluate for its 
Photostability. 
2. MATERIAL & METHODS 
2.1 Material:  
Nifedipine was obtained as a gift sample from Zydus 
Cadila ltd, Ahmadabad, India. Sepitrap 4000, Sepitrap 
80 were gifted by Seppic, Mumbai. All other chemicals 
and solvents used were of pharmaceutical and analytical 
grade. Double distilled water was used throughout the 
study for all the experimental procedures. 
2.2 Preparation of Nifedipine & Sepitrap Physical 
mixture:  
The 100 mg of Nifedipine weighed accurately & 
physical mixtures of Nifedipine with Sepitrap 80 & 
Sepitrap 4000 was prepared by simple spatulation 
method in the various proportions like 1:1 & 1:2. 
16 -18
. 
Various proportion used for physical mixtures was 
depicted in table no.1 
 
Table 1: Physical mixtures of Nifedipine with Sepitrap 80 & Sepitrap 4000 
Batch No  Drug (mg) SEPITRAP 80 (mg) SEPITRAP 4000 (mg) 
PM1 100 100    (1:1 ratio) --- 
PM2 100 200    (1:2 ratio) --- 
PM3 100 --- 100  (1:1 ratio) 
PM4 100 --- 200  (1:2 ratio) 
 
2.3 Characterization of Nifedipine & Sepitrap 
Physical Mixtures:  
2.3.1 Saturation solubility studies 
A saturation solubility study was carried out to deter-
mine increase in the solubility of pure Nifedipine 
19
 
compared with the Physical mixtures of Nifedipine with 
Sepitrap 80 & sepitrap 4000. Excess amount of the 
drug& Physical mixtures of Nifedipine with Sepitrap 80 
& sepitrap 4000 were added to the 250 mL conical 
flasks containing 25 mL of double distilled water. Then 
flasks were covered with cellophane membrane to avoid 
any loss of solvent and then kept in rotary shaker for 48 
h at 37± 0.5
0
C. The extra care was taken by covering the 
flask with black paper to protect the drug from photo 
degradation studies by considering photosensitive nature 
of Nifedipine. Aliquots were then withdrawn and filter 
through Whatman filter paper. The concentration of 
Nifedipine was determined by using UV visible 
spectrophotometer at 238nm (Shimadzu UV 
spectrophotometer 1800) after appropriate dilution 
20.
 
Three determinations were carried out for each sample 
to calculate the solubility of Nifedipine. The solubility 
of Nifedipine and percent increase in solubility due to 
use of sepitrap 80 & sepitrap4000 are depicted in figure 
no.1 
2.3.2 Fourier Transform Infrared spectrophotometer 
studies:  
FT-IR has been employed as a useful tool to identify 
drug excipient interaction. Samples were analyzed by 
the potassium bromide pellet method in an IR 
spectrophotometer (Alpha T Bruker) in the region from 
4000 to 400 cm
-1
. Physical mixtures of drug with 
sepitrap 80 & sepitrap 4000 were evaluated by 
comparing FT-IR spectra of physical mixtures to that of 
pure drug spectra. The FT-IR spectra of Pure 
Nifedipine, Physical mixture of Nifedipine- Sepitrap 80 
& Physical mixture of Nifedipine- Sepitrap 4000 are 
shown in figure No.2 
2.3.4 Differential scanning calorimeter (DSC) 
Analysis: 
Differential scanning calorimetry (DSC) has been one of 
the most widely used calorimetric techniques to study 
the solid state interaction of drug with Physical mixtures 
[21]. Samples of the pure drug & physical mixture of 
drug sepitrap  were taken in flat-bottomed aluminum 
pans and heated over a temperature range of 30 to 300 
°C at a constant rate of 10°/min with purging of nitrogen 
(50 ml/min) using alumina as a reference standard in a 
differential scanning calorimeter ( Mettler Toledo, 
Staresw 920). The DSC thermogram of Pure Nifedipine, 
Physical mixture of Nifedipine- Sepitrap 80 & Physical 
mixture of Nifedipine- Sepitrap 4000 are shown in 
figure No.3 
2.3.5 Powder X-ray diffractometry (PXRD) Analysis: 
The Powder X-ray diffraction technique has been 
extensively utilized along with DSC to study the interac-
tion & to obtain the changes in the crystallanity of the 
physical mixtures of drug sepitrap prepared, the PXRD 
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study was carried out by using X-ray diffractometer 
(Miniflex 600 X-ray diffractometer, Rigaku corporation 
Japan ) For this the samples of pure drug, physical 
mixtures of Nifedipine-sepitrap 80 &  Nifedipine-
sepitrap 4000 were irradiated with monochromatised 
CuKα radiation and analyzed between from 5° to 60° 
(2θ). The PXRD Diffractograms of Pure Nifedipine, 
Physical mixture of Nifedipine with sepitrap 80 & 
sepitrap 4000 are shown in figure no.4 
2.3.6 Scanning Electron Microscopy (SEM) studies:  
The surface morphology of pure Nifedipine & physical 
mixture of Nifedipine with Sepitrap 80 and sepitrap 
4000 was observed by using a scanning electron 
microscope (VEG A3 TESCAN), under accelerating 
voltage of 15 keV. Samples were fixed on SEM stub 
with double-sided adhesive tape and then coated in a 
vacuum with thin gold layer before investigation. The 
SEM images of Nifedipine and its physical mixtures 
with sepitrap 80 & sepitrap 4000 are shown in figure 5 
2.3.7 Photostability studies:  
The Nifedipine is most photosensitive drug hence 
Photostability studies of pure Nifedipine & physical 
mixture of Nifedipine with sepitrap 4000 were done by 
exposing these samples to the fluorescent light using 
Photostability chamber (TP 00000906, Thermo lab). 
The Samples were assayed for their content of 
Nifedipine prior to exposure and at 4, 8, 12, 24, 36, and 
60 h of continuous exposure using HPLC assay method. 
The chromatograms of pure Nifedipine and its physical 
mixture with sepitrap at different time interval are 
shown in fig no 6  
2.3.8 Dissolution studies in SGF & SIF:  
An accurately weighed amount of Nifedipine, physical 
mixture (equivalent to 20mg) of Nifedipine with 
sepitrap 80 & sepitrap 4000 in 1:1 & 1:2 proportion 
were weighed and added to the dissolution medium. The 
dissolution study was performed in simulated gastric 
fluid (pH 1.2) & simulated intestinal fluid ( pH 6.8 ) 
.The dissolution study was carried out using USP 
apparatus II (Shimadzu UV spectrophotometer 1800) at 
37+0.5 
O
C and 100 rpm paddle speed. The samples were 
withdrawn from dissolution media at specified time 
interval up to 120 min and the absorbance of the sample 
was recorded using UV spectrophotometer at 238 nm.
15
. 
The various dissolution profiles shown in figure no 7. 
2.3.9   Stability Study:  
Stability Study for Nifedipine –Sepitrap 4000 physical 
mixture (1:2 ratios) was carried out with the help of 
stability chamber (Remi SC-19 Plus) by storing 1gm of 
above physical mixture in an ambered colored screw 
capped glass bottles at accelerated and controlled 
temperatures 40
0
C and relative humidities (75%) for a 
period of 3 months. [32-34] Physical mixture was 
evaluated for physical appearance and in-vitro 
dissolution at the end of three months. 
3. RESULT & DISCUSSION 
3.1 Saturation solubility studies: 
There was remarkable enhancement in the solubility of 
Nifedipine in presence of Sepitrap 80 and sepitrap 4000 
compared to pure Nifedipine was observed in the 
saturation solubility studies. Pure Nifedipine exhibited a 
solubility of 8.30 ± 0.03 μg/mL in distilled water. The 
physical mixture of Nifedipine with sepitrap 80 in the 
proportion of 1:1 & 1:2 exhibited a solubility of 15.52 ± 
0.04 and 21.90± 0.09 μg/mL respectively. The physical 
mixture of Nifedipine with sepitrap 4000 in the 
proportion of 1:1 & 1:2 exhibited a solubility of 22.43 ± 
0.08 and 30.59 ± 0.02 μg/mL respectively. There was 
263 % increase in the solubility in case of physical 
mixture of Nifedipine with sepitrap 80 in higher 
proportion that is 1:2 whereas 368 % increase in the 
solubility in case of physical mixture of Nifedipine with 
sepitrap 4000 in higher proportion that is 1:2. The 
enhancement in solubility of Nifedipine in presence of 
sepitrap 80 as well as sepitrap4000 clearly indicates the 
novel solubilizer in powder form that is Polysorbate 80 
(sepitrap 80) & Polyoxyl 40 hydrogenated castor oil 
(sepitrap 4000) is promising for enhancement of 
solubility of poorly soluble drug. The solubility of 
Nifedipine and percent increase in solubility due to use 
of sepitrap 80 & sepitrap4000 are depicted in figure no.1 
 
 
Figure 1: Saturation solubility of Nifedipine in distilled water with different proportions of   sepitrap80 & sepitrap4000. 
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3.2 Fourier Transform Infrared spectrophotometer 
studies: 
The FT-IT analysis has been carried out in order to study 
interaction between Nifedipine and its physical mixture 
with sepitrap80 & sepitrap 4000. Pure Nifedipine 
showed IR absorption bands at 1689 cm
-1
 for ester 
carbonyl stretching band, 1122 cm
-1
 and 1125 cm
-1 
for 
ether absorption bands of C3 and C5 respectively .The 
absorption band 1625, 1574 cm
-1 
were denoted for 
stretching vibration of C=C in the aromatic ring. The IR 
absorption peak at 1310 cm
-1
 and 1529.6 cm
-1
 denotes 
nitro group. The peak at 3333.10 cm
-1 
denotes N-H 
stretching. Pure IR spectra of sepitrap80 & sepitrap 4000 
shows characteristics peaks and matches with standard 
reported peaks. The physical mixture of Nifedipine with 
sepitrap 80 & sepitrap4000 does not showed any new 
peaks and also retained principle IR peaks of pure 
Nifedipine which clearly indicates there is no any 
significant and unexpected interaction between 
Nifedipine and sepitrap. The overall results of FT-IR 
showed that sepitrap can be used as solubilizer for 
enhancement of solubility and dissolution rate as it 
found compatible with Nifedipine. FI-IR spectra of Pure 
Nifedipine, physical mixture of Nifedipine with sepitrap 
80 & sepitrap4000 are shown in figure no.2 
 
 
Figure 2: FT-IT Spectra of A] Pure Nifedipine, B] Physical Mixture of Nifedipine- Sepitrap 80 & C] Physical Mixture 
of Nifedipine –Sepitrap 400 
3.3 Differential scanning calorimeter (DSC) Analysis:  
Thermal analysis was also employed to evaluate drug 
crystallanity and to demonstrate any unexpected 
interaction between Nifedipine and sepitrap. A Sharp 
endothermic peak with an onset 172
0
C and peak at 
173.54
0
C correspond to melting point of Nifedipine. The 
physical mixture of Nifedipine with sepitrap 80 showed 
broadening of peak with reducing peak intensity and 
actual peak observed at 166.96
0
C. The physical mixture 
of Nifedipine with sepitrap4000 also showed broadening 
of peak with reducing peak intensity and actual peak 
observed at 169.12
0
C. The peak broadening, reducing 
intensity and early onset as comparing to the pure 
Nifedipine indicates sepitrap 80 as well as sepitrap 4000 
useful to reduction in drug's crystallanity and the 
dominance of its amorphous form which definitely affect 
in enhancement of solubility. The marked broadening 
and distinct reduction in intensity with shifting of drug 
endotherm was displayed physical mixture with sepitrap 
80 and sepitrap 4000 demonstrate positive effect. The 
physical mixture sepitrap and drug only showed a 
reduction in onset of melting and peak value but there is 
no new peaks were found, this result revealed that there 
is no significant and unexpected interaction between 
drug and sepitrap 80 as well as sepitrap4000. The DSC 
thermogram of Pure Nifedipine, Sepitrap 80 & Sepitrap 
4000 are shown in fig no. 3 
 
 
Figure 3: DSC Thermograms of A] Pure Nifedipine, B] Physical Mixture of Nifedipine- Sepitrap 80 & C] Physical 
Mixture of Nifedipine –Sepitrap 4000 
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3.4 Powder X-ray diffractometry (PXRD) Analysis:  
Powder X-ray diffraction spectroscopy has been used to 
assess the degree of crystallanity of the given sample. 
When physical mixture of drug with sepitrap 80 & 
sepitrap 4000 are formed, the overall number of 
crystalline structures is reduced and the number of 
amorphous structures is increased. Thus, the final 
product sample shows fewer, less intense peaks. This 
shows that overall crystallanity of complexes is de-
creased and due to a more amorphous nature, solubility 
is increased. The powder X-ray diffractograms of pure 
Nifedipine showed numerous distinctive peaks at 11.68, 
11.70, 11.72, 11.74, 16.12 etc that indicated a high 
crystallanity. The physical mixture of Nifedipine with 
Sepitrap 80 & sepitrap 4000 distinctive peaks but 
reduction in peak intensity in terms of counts. No new 
peak was detected and hence there was no unfavorable 
interaction of the drug with sepitrap taking place. IR and 
DSC studies support the same data, which is confirmed 
by x‐ray diffractometry. The PXRD Diffractograms of 
Pure Nifedipine, Physical mixture of Nifedipine with 
sepitrap 80 & sepitrap 4000 are shown in figure no.4 
 
 
Figure 4: PXRD diffractograms for A] Pure Nifedipine, B] Physical Mixture of Nifedipine- Sepitrap 4000 & C] 
Physical Mixture of Nifedipine –Sepitrap 80 
 
3.5 Scanning Electron Microscopy (SEM) studies:  
The SEM study was done to check surface morphology 
of the drug particles and its relevant changes when 
mixed with solubilizer in powder for in various 
proportions as a physical mixture. Nifedipine particles 
were variable shaped with rough surface and exhibiting 
loose aggregates of irregular shape. The SEM of 
physical mixture of Nifedipine with sepitrap 80 not 
shows significant change in its surface morphology due 
to no use any solvent during the physical mixture 
preparation. The SEM study carried out on physical 
mixture of drug with sepitrap in two different ratios that 
is 1:1 & 1:2 to identify effect of concentration of 
solubilizer on surface morphology of Nifedipine. The 
SEM images of sepitrap4000 –Drug physical mixture 
shows slight changes in its surface structure due to 
hydrogenated castor oil in solid form. The slight change 
in structure also responsible for the enhancement of 
solubility when comes in contact with fluid medium. 
The SEM images of Nifedipine and its physical 
mixtures with sepitrap 80 & sepitrap 4000 are shown in 
figure 5 
 
 
Figure5: SEM images of  A] Pure Nifedipine, B] Physical Mixture of Nifedipine- Sepitrap 80 1:1 ratio  & C] Physical 
Mixture of Nifedipine –Sepitrap 4000 1:1 ratio  D] Physical Mixture of Nifedipine –Sepitrap 4000 1:2 ratio   
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3.6 Photostability studies:  
The decomposition of Pure Nifedipine was found to be 
very marked upon exposure to fluorescent lamp or 
sunlight (which is the main source of light during 
manufacturing, storage and handling). The retention 
time for Nifedipine and its degradation product was 
found to be 14.02 ± 0.11 and 11.45 ± 0.24 respectively, 
thus it was clearly observed from the chromatograms 
that time required for 50% degradation of pure 
Nifedipine &  Physical mixture with sepitrap  was found 
to be  around 8 & 12 h respectively. Time required for 
complete degradation of pure Nifedipine & Physical 
mixture with sepitrap around 24 h and more than 36 h 
respectively. This study indicates that the rate of photo 
degradation is very slow in Physical mixture with 
sepitrap as compared to pure Nifedipine .The physical 
mixture containing sepitrap 4000 may  protects the 
Nifedipine from photodegradation as the 
photodegradation is surface phenomenon and sepitrap 
protect Nifedipine from direct exposure of light. The 
chromatograms of pure Nifedipine and its physical 
mixture with sepitrap at different time interval are 
shown in fig no 6 
    
 
Figure 6: chromatograms of A] Pure Nifedipine at different time interval B] Nifedipine-Sepitrap 4000 physical mixture 
at different time interval 
3.7 In-Vitro Dissolution studies in SGF & SIF:  
The dissolution study was carried out in simulated 
gastric fluid as well as simulated intestinal fluid. The 
pure Nifedipine shows drug dissolution of 16. 24 & 
18.21 % in 30 min in SGF & SIF respectively, Physical 
mixture of Nifedipine with sepitrap 80 in 1: 2 proportion 
shows 56.78 & 63.22%  drug dissolution  in 30 min 
while  Physical mixture of Nifedipine with sepitrap 
4000 in 1: 2 proportion shows 70.28  & 71.54 % drug 
dissolution in SGF & SIF respectively. The dissolution 
of Nifedipine was significantly enhanced by use of 
novel solubilizer sepitrap 80 as well as sepitrap 4000 in 
1:2 proportions. The enhancement in Nifedipine 
dissolution was explained to be mainly due to the 
increase in both wettability and solubility. The solubility 
of pure Nifedipine increased due to localized 
solubilization in presence of novel solubilizer sepitrap 
80 &sepitrap 4000 resulted in overall increase in 
dissolution rate. The Physical mixture containing 
Nifedipine –sepitrap 80 in 1:2 proportion shows similar 
dissolution profile compare to physical mixture 
containing Nifedipine –sepitrap 4000 in 1:1 proportion 
indicate that sepitrap 4000 is more potential and 
effective solubilizer as compare to sepitrap 80 in exactly 
half quantity to that of sepitrap80. The dissolution 
profile of all physical mixture in simulated gastric fluid 
& simulated intestinal fluid not shows any significant 
difference indicating novel solubilizer sepitrap 80 as 
well as sepitrap 4000 is effective as solubilization agent 
in various pH condition of GI tract. The dissolution 
profiles of various physical mixtures in simulated gastric 
fluid and simulated intestinal fluid are shown in figure 
No.7
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Figure 7: Dissolution profile in A] simulated gastric fluid pH 1.2 and B] Simulated intestinal fluid pH 6.8 
3.9 Stability studies:  
There was no significant change in the physical 
appearance and percent drug dissolution in the physical 
mixture of Nifedipine-sepitrap4000 in 1:2 ratio. A 
stability results clearly indicate that the physical mixture 
was sufficiently stable under accelerated and controlled 
conditions. The no change in physical appearance 
clearly indicates that sepitrap 4000 was stable under 
accelerated temperature condition and hence overall 
physical mixture containing drug remains stable. 
4. CONCLUSION 
The use of novel solubilizer sepitrap 80 & sepitrap4000 
in the form of simple physical mixture was proven to 
successful approach for solubility and dissolution rate 
enhancement of poorly soluble BCS class II drug 
Nifedipine. In-vivo pharmacokinetic study in albino rats 
clearly indicates that sepitrap 4000 in 1:2 proportions is 
most useful in the form simple physical mixture for 
enhancement of absorption of Nifedipine as compare to 
the drug alone. Nifedipine –sepitrap 4000 physical 
mixture can be used for further development in any 
suitable drug delivery technique where poor solubility of 
active ingredient becomes rate limiting step. 
5.  Acknowledgement 
Authors are thankful to the Zydus cadilla ltd 
Ahmadabad for providing gift sample of Nifedipine, 
Seppic India ltd for providing gift sample of sepitrap 80 
& sepitrap4000.   Shivaji University, Kolhapur and 
SGRS College of pharmacy Saswad is acknowledged 
for assistance with analytical work. 
 
6. REFERENCES 
1] Hiroyuki o. atsuo, M takurou, K yuji, M yasunori, I takashi, S 
shigeru,  Freeze-dried nifedipine-lipid nanoparticles with long-
term nano-dispersion  stability after reconstitution. Int. J. 
Pharm, 2009; 377:180-184. 
2] Mitchell S.A., Reynolds T.D., Dasbach T.P.,. A compaction 
process to enhance dissolution of poorly water-soluble drugs 
using hydroxypropyl methylcellulose. Int. J. Pharm. 2003; 
250:3–11. 
3] Sugimoto M., Okagaki T., Narisawa S., Koida Y., Nakajima K., 
Improvement of dissolution characteristics and bioavailability 
of poorly water-soluble drugs by novel co grinding method 
using water-soluble polymer. Int. J. Pharm. 1998; 160:11–19. 
4] Suzuki H., Ogawa M., Hironaka K., Ito K., Sunada, H. A 
nifedipine coground mixture with sodium deoxycholate. II. 
Dissolution characteristics and stability. Drug. Dev. Ind. 
Pharm., 2001; 27:951–958. 
5] Zajc N., Obreza A., Bele M., Srcic S., Physical properties and 
dissolution behaviour of nifedipine/mannitol solid dispersions 
prepared by hot melt method. Int. J. Pharm. 2005; 291:51–58. 
6] Yamamura S., Rogers J.A., Characterization and dissolution 
behavior of Nifedipine and phosphatidyl choline binary 
systems. Int. J. Pharm. 1996; 130:65–73. 
7] Cilurzo F., Minghetti P., Casiraghi A., Montanari L., 
Characterization of Nifedipine solid dispersions. Int. J. Pharm. 
2002; 242:313–317. 
8] Portero A., Remunan-Lopez C., Vila-Jato J.L., Effect of 
chitosan and chitosan glutamate enhancing the dissolution 
properties of the poorly water soluble drug nifedipine. Int. J. 
Pharm. 1998; 175: 75–84. 
9] Lin C.-W., Cham T.M., Effect of particle size on the available 
surface area of nifedipine from Nifedipine–polyethylene glycol 
6000 solid dispersions. Int. J. Pharm. 1996; 127:261–272. 
10] Vippagunta S.R., Maul K.A., Tallavajhala S., Grant, D.J.W., 
Solid-state characterization of nifedipine solid dispersions. Int. 
J. Pharm. 2002; 236:111–123. 
11] Hirayama F., Wang Z., Uekema K., Effect of 2- 
hydroxypropyl-beta-cyclodextrin on crystallisation and 
polymorphic transition of nifedipine in solid state. Pharm. Res. 
1994; 111:1766–1770. 
12] Ramyasree domala, basanth babu eedara, rajeshri k. Dhurke, 
Development of Pulsatile Drug Delivery System Using Novel 
Solubilizers For Antihypertensive Drug, International Journal of 
Pharmacy and Pharmaceutical Sciences, 2014; 6:659-664 
13] Albini A and Fasani E. Photochemistry of Drug: an Overview 
and Practical Problems. In: Albini A and Fasani E. (Eds.) Drug 
Jagtap et al                                                                                                     Journal of Drug Delivery & Therapeutics. 2018; 8(5-s):293-300           
ISSN: 2250-1177                                                                             [300]                                                                             CODEN (USA): JDDTAO 
Photochemistry and Photostability. 1st ed. The Royal Society of 
Chemistry, Cambridge 1998; 1-65. 
14] Majeed IA, Murray WJ, Newton DW, Othman S, and Al-Turk 
WA. Spectrophotometric study of the photodecomposition 
kinetics of Nifedipine. J. Pharm. Pharmacol. 1987; 39:1944-
1946 
15] Dokladalov J, Tykal JA and Coco SJ. Occurrence and 
measurement of nifidipine and its nitropyridine derivative in 
human blood plasma. J. Chromatog. 1982; 231:451-458 
16] Reddy RK, Veera JM, Mohamed Saleem TS, MadhuSudhana 
CC. Review on: pulsatile drug delivery systems J Pharm Sci 
Res, 2009; 4:109-115. 
17] Kim EJ, Chun MK, Jang JS, Lee IH, Choi HK. Preparation of 
a solid dispersion of felodipine using a solvent wetting method 
Eur J Pharm Biopharm  2006; 64:200-205 
18] Won DH, Kim MS, Lee s, Park JS, Hwang SJ. Improved 
physicochemical characteristics of felodipine solid dispersion 
particles by supercritical anti-solvent precipitation process .Int J 
Pharm 2005; 301:199-208 
19] Swati Changdeo Jagdale,, Vinayak Narhari Jadhav, Aniruddha 
Rajaram Chabukswar, Bhanudas Shankar Kuchekar, Solubility 
enhancement, physicochemical characterization and formulation 
of fast-dissolving tablet of nifedipine-betacyclodextrin 
complexes, Brazilian Journal of  Pharmaceutical Sciences, 
2012; 48:131-145 
 20] Naveen A, katare O, singh B, Studies on dissolution 
enhancement and mathematical modeling of drug release of a 
poorly water-soluble drug using water-soluble carriers. Eur. J. 
Pharm. Biopharm  2007; 65:26-38. 
21]  Ramana MV, Himaja  M,  Dua K, A new approach: 
enhancement of solubility of rofecoxib. Asian J. Pharm., 2008; 
2: 96-101. 
22] Indian pharmacopoeia Government of India, ministry of health 
and family welfare’s, published by the controller of 
publications, The Indian pharmacopoeia commission 
Ghaziabad. 2007; 3:177-186,447,1442-1445. 
23] Jagdale S, kuchekar B, chabukswar A,  Musale V, Jadhao M, 
Preparation and in vitro evaluation of Allopurinol-Gelucire 
solid dispersions. Int. J. Adv. Pharm. Sci, 2010; 1:60-67. 
24] Friedrich H, Nada A, Bodmier R, Solid state and dissolution 
rate characterization of co-ground mixtures of nifedipine and 
hydrophillic carriers. Drug Dev. Ind. Pharm., 2005; 31:719-728. 
25] Lachman l, Lieberman h a, kaing JL, The theory and practice 
of industrial pharmacy. 4.ed. New Delhi CBS Publication, 1991 
26] Kulkarni G.T, Gowthamarajan K, Suresh B. stability testing of 
pharmaceutical product: an overview. Indian J Phar Edu  2004; 
38:194-202.  
27] Papadimitriou SA, Bikiaris D, Avgoustakis K. Microwave-
induced enhancement of the dissolution rate of poorly water-
soluble tibolone from poly (ethylene glycol) solid dispersions. J 
Appl Polymer Sci.  2008; 108:1249-1258.  
28] Mosab Arafat, Zahaa Ahmed, Momir Mikov,
 
determination of 
Nifedipine In Rat Plasma Using Hplc-Uv Detector: A Simple 
Method For Pharmacokinetics And Oral Bioavailability Studies 
International Journal of Pharmacy and Pharmaceutical Sciences,  
2016; 8:98-102 
29] Vertzoni MV, Reppas C, Archontaki HA. Sensitive and simple 
liquid chromatographic method with ultraviolet detection for the 
determination of nifedipine in canine plasma. Anal Chim Acta 
2006; 573-574 
30] Thongnopnua P, Viwatwongsa K. Quantitative analysis of 
Nifedipine in plasma by high-performance liquid 
chromatography. J Pharm Biomed Anal 1994; 129: 119-25.  
31] Grundy JS, Kherani R, Foster RT. Sensitive high-performance 
liquid chromatographic assay for nifedipine in human plasma 
utilizing ultraviolet detection. J Chromatogr B: Biomed  appl 
1994; 654:146-51.  
32] International conference on harmonization (ICH) harmonized 
tripartite guideline for stability testing of new drugs substances 
and products Q1A (R2) aug-2003. Q1 (R2) Mar 2004.  
33] Rhodes CT, Cartesan T. Drug stability principle and 
procedure, 3rd ed, New York, 2001  
34] Yi T, Wan J, Xu H, et al. A new solid self-micro emulsifying 
formulation prepared by spray-drying to improve the oral 
bioavailability of poorly water soluble drugs. Eur J Pharm 
Biopharm 2008; 70:439-444 
35] Rogers TL, Johnston KP, Williams III RO. Solution-based 
particle formation of pharmaceutical powders by supercritical or 
compressed fluid CO2 and cryogenic spray freezing 
technologies. Drug Dev Ind Pharm. 2001; 27:1003-1015
 
 
 
 
 
